Thomas Hübner

BM-T Beteiligungsmanagement Thüringen GmbH (BMT) is the investment arm and a wholly-owned subsidiary of Thüringen Aufbaubank, which in turn is part of Landesbank Hessen-Thüringen Girozentrale, also known as HELABA-Hessische Landesbank. HELABA is a regional bank in Länder Hessen and Thüringen, controlled but the Government of Germany. BMT was established in 2003 and is headquartered in Erfurt, the capital of Land Thüringen in central Germany. The firm invests on behalf of the German government, and is backed by Land Thüringen. They originally received capital from TBG-Technologie Beteiligungs GmbH as well. TBG is a Bonn-based private equity entity part of the government-controlled KfW Bankengruppe. BMT manages venture capital and private equity funds.

InflaRx GmbH operates as a biotech company which develops new therapeutics in the field of inflammation. It focuses on the general area of inflammation including indications such as SIRS and SEPSIS by applying innovative therapeutics in order to prevent organ dysfunction or limit progression into organ failure. The firm's complement system is activated and produces large amounts of products including complement 5a (C5a), C3a, C4a and membrane-attack complex (MAC). The company was founded in 2007 by Niels Riedemann and Renfeng Guo and is headquartered in Jena, Germany.

Part of Sparkassen- und Giroverband Hessen-Thüringen, Thüringer Aufbaubank, Anstalt des öffentlichen Rechts is a German company that provides banking services. The company is based in Erfurt, Germany. The private company was founded in 1992. Matthias Wierlacher has been the CEO of the company since 2002.

eZono AG develops portable ultrasound system. Its product eZono 3000 is a portable ultrasound system designed for the needs of anaesthetists. The company was founded by Allan R. Dunbar and Andre Jaekel in July 2004 and is headquartered in Jena, Germany.

JeNaCell GmbH develops biomaterials with nanostructures for applications in the medicine, cosmetics and technology sectors. The firm offers patented technology for the continuous production of biomaterials. The company was founded by Dr. Nadine Hessler in June 2012 and is headquartered in Jena, Germany.